Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amhwa Biopharm is a leading global supplier and manufacturer of high-quality hyaluronic acid and other bio-active ingredients, headquartered in Jinan, China. The company leverages a sophisticated microbial fermentation platform to produce a wide range of sodium hyaluronate grades, including pharmaceutical, cosmetic, and food-grade products. Their medical-grade offerings are utilized in critical applications such as intra-articular injections for osteoarthritis and viscoelastic agents for ophthalmic surgery. Beyond hyaluronic acid, Amhwa Biopharm develops innovative ingredients like Ectoine and Ergothioneine, catering to the pharmaceutical, nutraceutical, and personal care sectors. With a strong emphasis on R&D and international quality standards, the company maintains a significant presence in global markets through its GMP-certified manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amhwa Biopharm.